| Financial Year |
March 31 2023 |
| Monetary Funds |
1,312,233,483.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
263,981,937.30 |
| Advances to Suppliers |
128,549,787.20 |
| Other Receivables |
13,792,938.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
215,977,642.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,120,040.96 |
| Total Current Assets |
1,953,011,615.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
521,786,810.04 |
| Investment Properties |
60,500,593.47 |
| Fixed Assetes |
8,178,447,396.40 |
| Under-construction Projects |
1,351,748,069.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
627,492,914.04 |
| R&D expenses |
22,250,510.57 |
| Goodwill |
144,919,962.37 |
| Long-Term Deferred and Prepaid Expenses |
1,294,767.90 |
| Deferred Income Tax Assets |
40,650,644.11 |
| Other Non-Current Assets |
165,468,914.50 |
| Sub-Total of Non-Current Assets |
11,117,146,076.46 |
| Total Assets |
13,070,157,692.21 |
| Short-Term Loans |
449,767,238.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,461,525,977.93 |
| Accounts Received In Advance |
198,765.52 |
| Employee Compensation Payable |
174,045,599.88 |
| Taxes Payable |
94,227,691.97 |
| Interest Payable |
-- |
| Dividend Payable |
4,900,000.00 |
| Other payables |
223,796,385.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
834,164,791.89 |
| Other Current Liabilities |
859,421,588.96 |
| Sub-Total of Current Liabilities |
4,812,301,378.20 |
| Long-term Loans |
470,429,312.94 |
| Bonds Payable |
516,928,987.55 |
| Long-Term Accounts Payable |
5,540,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,570,535.90 |
| Other Non-Current Liabilities |
152,696,000.58 |
| Sub-Total of Non-Current Liabilities |
1,206,974,845.05 |
| Total Liabilities |
6,019,276,223.25 |
| Paid-In Capital(Or Share Stock) |
1,112,075,445.00 |
| Capital Surplus |
1,247,455,622.16 |
| Surplus Reserve |
564,197,722.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,505,785,899.06 |
| Minority Stockholder's Interest |
289,095,528.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,761,785,940.04 |
| Owner's Equity（Stockholder's Equity） |
7,050,881,468.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,070,157,692.21 |
